ホルモン性子宮内避妊器具（IUD）の世界市場レポート 2025年

ホルモン性子宮内避妊器具（IUD）市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.7％で43億4,000万米ドルに成長します。予測期間における成長の背景には、避妊法の選択肢に対する意識の高まり、長時間作用型可逆的避妊法への嗜好の高まり、デバイスの安全性と有効性の進歩、個別化ヘルスケアの重視の高まり、ヘルスケアプロバイダーによる幅広い入手可能性などがあります。予測期間における主な動向としては、デバイス技術の進歩、避妊オプションの個別化の進展、患者中心のヘルスケアアプローチの成長、持続可能で環境に優しい製品に対する需要の高まり、新しい避妊製品の開発などが挙げられます。

望まない妊娠の発生率の上昇が、今後のホルモン性子宮内避妊具市場の成長を促進すると予測されます。望まない妊娠とは、妊娠時に計画されていなかったり望まれていなかったりする妊娠のことで、避妊の失敗、避妊具へのアクセス不足、避妊具の不適切な使用、性的暴力など、さまざまな要因から生じる可能性があります。効果的な避妊法へのアクセスが限られていると、生殖の選択に対する個人のコントロールが弱まり、望まない妊娠の可能性が高まる。ホルモンIUDは妊娠を防ぐのに非常に効果的で、失敗率は1％未満です。長期間の保護（種類によって3～7年）を提供し、意図しない妊娠を避けたい人にとって信頼できる選択肢となります。例えば、2023年8月、保健社会医療省内の英国政府機関である健康改善・格差対策室は、2022年1月から6月までの間に、イングランドとウェールズの住民の中絶件数は12万3,219件で、2021年の同時期と比べて17％増加したと報告しました。このように、望まない妊娠の増加がホルモン性子宮内避妊具市場の成長に寄与しています。

ホルモン性子宮内避妊器具市場の主なプレーヤーは、レボノルゲストレル放出子宮内システムなどの先進製品の開発に注力し、女性により個別化された避妊ソリューションを提供しています。レボノルゲストレル放出子宮内避妊システム（LNG-IUS）は、子宮内に合成黄体ホルモンであるレボノルゲストレルを安定的に放出するホルモン性IUDです。このホルモンは子宮頸管粘液を濃くし、子宮内膜を変化させ、精子が卵子に到達するのを防ぐ。例えば、2022年11月、必須医薬品と健康製品への女性のアクセス改善に取り組む米国の製薬団体Medicines360は、FDA承認のLILETTAを発売しました。リレッタは米国で入手可能なホルモン性IUDの中で最も長持ちするものひとつで、避妊効果は最長8年、月経多量出血の治療効果は最長5年まで承認されています。このIUDは、さまざまな人々の妊娠を防ぐのに約99％の効果があります。人間工学に基づいた挿入器が付属しており、診察時に簡単に装着でき、ヘルスケアプロバイダーがいつでも取り外すことができます。処方箋により入手可能で、リレッタは340B薬価プログラムを通じて割引価格で提供され、女性のヘルスケアへのアクセスを強化するというMedicines360の使命に合致しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ホルモン性子宮内避妊器具（IUD） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のホルモン性子宮内避妊器具（IUD）市場：成長率分析
• 世界のホルモン性子宮内避妊器具（IUD）市場の実績：規模と成長, 2019-2024
• 世界のホルモン性子宮内避妊器具（IUD）市場の予測：規模と成長, 2024-2029, 2034F
• 世界ホルモン性子宮内避妊器具（IUD）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のホルモン性子宮内避妊器具（IUD）市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 13ミリグラムのホルモン性子宮内避妊器具
• 19ミリグラムのホルモン性子宮内避妊器具
• 52ミリグラムのホルモン性子宮内避妊器具
• 世界のホルモン性子宮内避妊器具（IUD）市場デバイス設計による、実績と予測, 2019-2024, 2024-2029F, 2034F
• フレーム付き子宮内避妊器具
• フレームレス子宮内避妊器具
• 世界のホルモン性子宮内避妊器具（IUD）市場ホルモンの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• レボノルゲストレル放出子宮内避妊器具
• プロゲステロン放出子宮内避妊器具
• 世界のホルモン性子宮内避妊器具（IUD）市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 20～24歳
• 25～34歳
• 35～44歳
• その他の用途
• 世界のホルモン性子宮内避妊器具（IUD）市場13ミリグラムのホルモン性子宮内避妊器具の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 低用量13mgのIUD
• 特定の症状に適した13mgの特殊IUD
• 世界のホルモン性子宮内避妊器具（IUD）市場19ミリグラムのホルモン性子宮内避妊器具の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 低用量19mgのIUD
• 特定の症状に適した19mgの特殊IUD
• 世界のホルモン性子宮内避妊器具（IUD）市場52ミリグラムのホルモン性子宮内避妊器具の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準52mg IUD
• 徐放性52mg IUD
• 月経過多や子宮内膜症におすすめの52mg子宮内避妊器具

第7章 地域別・国別分析

• 世界のホルモン性子宮内避妊器具（IUD）市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のホルモン性子宮内避妊器具（IUD）市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ホルモン性子宮内避妊器具（IUD）市場：競合情勢
• ホルモン性子宮内避妊器具（IUD）市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Organon & Companies Overview, Products and Services, Strategy and Financial Analysis
  • Gedeon Richter Plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Meril Life Science Pvt Ltd.
• Bharat Serums and Vaccines Limited
• Teva UK Limited
• EurimPharm
• HRA Pharma SAS
• Medicines360
• Hll Lifecare Limited
• Pregna International Ltd.
• Allergan plc
• Actavis Inc.
• DKT WomanCare Global
• CrossBay Medical Inc.
• SMB Corporation of India
• Oy Leiras
• OCON Healthcare

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ホルモン性子宮内避妊器具（IUD）市場2029：新たな機会を提供する国
• ホルモン性子宮内避妊器具（IUD）市場2029：新たな機会を提供するセグメント
• ホルモン性子宮内避妊器具（IUD）市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Hormonal intrauterine devices (IUDs) are small, T-shaped plastic devices that are inserted into the uterus and release progestin, a synthetic hormone. These devices prevent pregnancy by thickening cervical mucus to block sperm, thinning the uterine lining to impede implantation, and sometimes suppressing ovulation. Additionally, they can reduce menstrual bleeding and cramping, and in some cases, may stop periods altogether.

The primary types of hormonal IUDs include 13-milligram, 19-milligram, and 52-milligram hormonal IUDs. The 13-milligram hormonal IUDs, which release a low dose of hormones for up to three years, are becoming increasingly popular among women seeking long-acting contraceptive options with lower hormone exposure. The design of these devices varies, including framed and frameless IUDs, and they feature different hormone types such as levonorgestrel-releasing and progesterone-releasing IUDs. These options cater to various age groups, including those aged 20-24, 25-34, and 35-44, among other applications.

The hormonal intrauterine devices (IUDs) market research report is one of a series of new reports from The Business Research Company that provides hormonal intrauterine devices (IUDs) market statistics, including hormonal intrauterine devices (IUDs) industry global market size, regional shares, competitors with a hormonal intrauterine devices (IUDs) market share, detailed hormonal intrauterine devices (IUDs) market segments, market trends, and opportunities, and any further data you may need to thrive in the hormonal intrauterine devices (IUDs) industry. This hormonal intrauterine device (IUDs) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hormonal intrauterine devices (IUDs) market size has grown rapidly in recent years. It will grow from $2.61 billion in 2024 to $2.89 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to the development of safer and more effective hormonal formulations, rising demand for long-term birth control solutions, increasing healthcare provider recommendations, greater public awareness of contraceptive options, and advancements in medical technology and device design.

The hormonal intrauterine devices (IUDs) market size is expected to see rapid growth in the next few years. It will grow to $4.34 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to rising awareness of contraceptive choices, increasing preference for long-acting reversible contraception, advancements in device safety and efficacy, growing emphasis on personalized healthcare, and broader availability through healthcare providers. Major trends in the forecast period include advancements in device technology, increasing personalization of contraceptive options, growth in patient-centric healthcare approaches, rising demand for sustainable and eco-friendly products, development of new contraceptive products.

The rising incidence of unwanted pregnancies is projected to drive the growth of the hormonal intrauterine devices market in the future. Unwanted pregnancies refer to those that are not planned or desired at the time of conception and can arise from various factors, such as contraceptive failure, lack of access to birth control, improper use of contraception, or sexual violence. Limited access to effective contraceptive methods diminishes individuals' control over their reproductive choices, increasing the likelihood of unwanted pregnancies. Hormonal IUDs are highly effective in preventing pregnancy, boasting a failure rate of less than 1%. They offer long-term protection (ranging from 3 to 7 years, depending on the specific type) and serve as a reliable option for those looking to avoid unintended pregnancies. For example, in August 2023, the Office for Health Improvement & Disparities, a UK governmental unit within the Department of Health and Social Care, reported that between January and June 2022, there were 123,219 abortions among residents of England and Wales, representing a 17% increase compared to the same period in 2021. Thus, the rise in unwanted pregnancies is contributing to the growth of the hormonal intrauterine devices market.

Key players in the hormonal intrauterine devices market are focusing on developing advanced products, such as levonorgestrel-releasing intrauterine systems, to offer more personalized contraceptive solutions for women. Levonorgestrel-releasing intrauterine systems (LNG-IUS) are hormonal IUDs that steadily release levonorgestrel, a synthetic progestin, into the uterus. This hormone thickens cervical mucus and modifies the uterine lining, preventing sperm from reaching the egg. For instance, in November 2022, Medicines360, a US-based pharmaceutical organization dedicated to improving women's access to essential medicines and health products, launched the FDA-approved LILETTA. LILETTA is one of the longest-lasting hormonal IUDs available in the U.S., approved for contraception for up to 8 years and for treating heavy menstrual bleeding for up to 5 years. It is approximately 99% effective in preventing pregnancy among diverse populations. The device comes with an ergonomic inserter for easy placement during a consultation and can be removed at any time by a healthcare provider. It is available by prescription, and LILETTA is offered at a reduced price through the 340B drug pricing program, aligning with Medicines360's mission to enhance access to women's healthcare.

In January 2024, Medicines360 formed a partnership with DKT WomanCare Global, a France-based company focused on the availability, accessibility, and affordability of sexual and reproductive health products for women. This strategic collaboration aims to enhance the availability and accessibility of the affordable hormonal IUD, Avibela, by raising awareness and expanding market reach, particularly in underserved areas, and is intended to improve global sexual and reproductive health.

Major companies operating in the hormonal intrauterine devices (IUDs) market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Bharat Serums and Vaccines Limited, Teva UK Limited, EurimPharm Produktions GmbH, HRA Pharma SAS, Medicines360, Hll Lifecare Limited, Pregna International Ltd., Allergan plc, Actavis Inc., DKT WomanCare Global, CrossBay Medical Inc., SMB Corporation of India, Oy Leiras, OCON Healthcare

North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (IUDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hormonal intrauterine devices (IUDs) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hormonal intrauterine devices (IUDs) market consists of sales of hormone reservoir, strings, and insertion or removal instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hormonal Intrauterine Devices (IUDs) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hormonal intrauterine devices (iuds) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hormonal intrauterine devices (iuds) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hormonal intrauterine devices (iuds) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: 13 Milligram Hormonal Intrauterine Devices; 19 Milligram Hormonal Intrauterine Devices; 52 Milligram Hormonal Intrauterine Devices
• 2) By Device Design: Framed Intrauterine Devices; Frameless Intrauterine Devices
• 3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices; Progesterone Releasing Intrauterine Devices
• 4) By Application: Age 20-24; Age 25-34; Age 35-44; Other Applications
• Subsegments:
• 1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs; Specialty 13 Mg IUDs For Specific Conditions
• 2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs; Specialty 19 Mg IUDs For Specific Conditions
• 3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs; Extended-Release 52 Mg IUDs; Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis
• Companies Mentioned: Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Organon & Companies; Gedeon Richter Plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hormonal Intrauterine Devices (IUDs) Market Characteristics

3. Hormonal Intrauterine Devices (IUDs) Market Trends And Strategies

4. Hormonal Intrauterine Devices (IUDs) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Hormonal Intrauterine Devices (IUDs) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hormonal Intrauterine Devices (IUDs) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hormonal Intrauterine Devices (IUDs) Market Growth Rate Analysis
• 5.4. Global Hormonal Intrauterine Devices (IUDs) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hormonal Intrauterine Devices (IUDs) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hormonal Intrauterine Devices (IUDs) Total Addressable Market (TAM)

6. Hormonal Intrauterine Devices (IUDs) Market Segmentation

• 6.1. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13 Milligram Hormonal Intrauterine Devices
• 19 Milligram Hormonal Intrauterine Devices
• 52 Milligram Hormonal Intrauterine Devices
• 6.2. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Framed Intrauterine Devices
• Frameless Intrauterine Devices
• 6.3. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Levonorgestrel Releasing Intrauterine Devices
• Progesterone Releasing Intrauterine Devices
• 6.4. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Age 20-24
• Age 25-34
• Age 35-44
• Other Applications
• 6.5. Global Hormonal Intrauterine Devices (IUDs) Market, Sub-Segmentation Of 13 Milligram Hormonal Intrauterine Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Low-Dose 13 Mg IUDs
• Specialty 13 Mg IUDs For Specific Conditions
• 6.6. Global Hormonal Intrauterine Devices (IUDs) Market, Sub-Segmentation Of 19 Milligram Hormonal Intrauterine Devices,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Low-Dose 19 Mg IUDs
• Specialty 19 Mg IUDs For Specific Conditions
• 6.7. Global Hormonal Intrauterine Devices (IUDs) Market, Sub-Segmentation Of 52 Milligram Hormonal Intrauterine Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard 52 Mg IUDs
• Extended-Release 52 Mg IUDs
• Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis

7. Hormonal Intrauterine Devices (IUDs) Market Regional And Country Analysis

• 7.1. Global Hormonal Intrauterine Devices (IUDs) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hormonal Intrauterine Devices (IUDs) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market

• 8.1. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hormonal Intrauterine Devices (IUDs) Market

• 9.1. China Hormonal Intrauterine Devices (IUDs) Market Overview
• 9.2. China Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hormonal Intrauterine Devices (IUDs) Market

• 10.1. India Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hormonal Intrauterine Devices (IUDs) Market

• 11.1. Japan Hormonal Intrauterine Devices (IUDs) Market Overview
• 11.2. Japan Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hormonal Intrauterine Devices (IUDs) Market

• 12.1. Australia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hormonal Intrauterine Devices (IUDs) Market

• 13.1. Indonesia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hormonal Intrauterine Devices (IUDs) Market

• 14.1. South Korea Hormonal Intrauterine Devices (IUDs) Market Overview
• 14.2. South Korea Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hormonal Intrauterine Devices (IUDs) Market

• 15.1. Western Europe Hormonal Intrauterine Devices (IUDs) Market Overview
• 15.2. Western Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hormonal Intrauterine Devices (IUDs) Market

• 16.1. UK Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hormonal Intrauterine Devices (IUDs) Market

• 17.1. Germany Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hormonal Intrauterine Devices (IUDs) Market

• 18.1. France Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hormonal Intrauterine Devices (IUDs) Market

• 19.1. Italy Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hormonal Intrauterine Devices (IUDs) Market

• 20.1. Spain Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market

• 21.1. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market Overview
• 21.2. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hormonal Intrauterine Devices (IUDs) Market

• 22.1. Russia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hormonal Intrauterine Devices (IUDs) Market

• 23.1. North America Hormonal Intrauterine Devices (IUDs) Market Overview
• 23.2. North America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hormonal Intrauterine Devices (IUDs) Market

• 24.1. USA Hormonal Intrauterine Devices (IUDs) Market Overview
• 24.2. USA Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hormonal Intrauterine Devices (IUDs) Market

• 25.1. Canada Hormonal Intrauterine Devices (IUDs) Market Overview
• 25.2. Canada Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hormonal Intrauterine Devices (IUDs) Market

• 26.1. South America Hormonal Intrauterine Devices (IUDs) Market Overview
• 26.2. South America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hormonal Intrauterine Devices (IUDs) Market

• 27.1. Brazil Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hormonal Intrauterine Devices (IUDs) Market

• 28.1. Middle East Hormonal Intrauterine Devices (IUDs) Market Overview
• 28.2. Middle East Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hormonal Intrauterine Devices (IUDs) Market

• 29.1. Africa Hormonal Intrauterine Devices (IUDs) Market Overview
• 29.2. Africa Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hormonal Intrauterine Devices (IUDs) Market Competitive Landscape And Company Profiles

• 30.1. Hormonal Intrauterine Devices (IUDs) Market Competitive Landscape
• 30.2. Hormonal Intrauterine Devices (IUDs) Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Organon & Companies Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Gedeon Richter Plc Overview, Products and Services, Strategy and Financial Analysis

31. Hormonal Intrauterine Devices (IUDs) Market Other Major And Innovative Companies

• 31.1. Meril Life Science Pvt Ltd.
• 31.2. Bharat Serums and Vaccines Limited
• 31.3. Teva UK Limited
• 31.4. EurimPharm
• 31.5. HRA Pharma SAS
• 31.6. Medicines360
• 31.7. Hll Lifecare Limited
• 31.8. Pregna International Ltd.
• 31.9. Allergan plc
• 31.10. Actavis Inc.
• 31.11. DKT WomanCare Global
• 31.12. CrossBay Medical Inc.
• 31.13. SMB Corporation of India
• 31.14. Oy Leiras
• 31.15. OCON Healthcare

32. Global Hormonal Intrauterine Devices (IUDs) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hormonal Intrauterine Devices (IUDs) Market

34. Recent Developments In The Hormonal Intrauterine Devices (IUDs) Market

35. Hormonal Intrauterine Devices (IUDs) Market High Potential Countries, Segments and Strategies

• 35.1 Hormonal Intrauterine Devices (IUDs) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hormonal Intrauterine Devices (IUDs) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hormonal Intrauterine Devices (IUDs) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer